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Abstract To investigate the possible influence of the local rates
of translation on protein folding, 16 consecutive rare (in
Escherichia coli) codons in the chloramphenicol acetyltransferase
(CAT) gene have been replaced by frequent ones. Site-directed
silent mutagenesis reduced the pauses in translation of CAT in E.
coli S30 extract cell-free system and led to the acceleration of the
overall rate of CAT protein synthesis. At the same time, the
silently mutated protein (with unaltered protein sequence)
synthesized in the E. coli S30 extract system was shown to
possess 20% lower specific activity. The data suggest that
kinetics of protein translation can affect the in vivo protein-
folding pathway, leading to increased levels of protein misfolding.
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1. Introduction
Protein folding still remains the most intriguing and puz-
zling problem in molecular biology. Many proteins could be
successfully refolded in aqueous solutions, but their folding
pathway in vivo is thought to be a¡ected by a lot of factors,
such as viscosity of cytoplasm, local pH values, concentration
and activity/a⁄nity of surrounding macromolecules and many
others (for review see [1,2]). Folding of some proteins in a cell
is also facilitated by chaperones, known to prevent proteins
and newly synthesized nascent chains from misfolding and
aggregation [1^5]. In addition, folding in vivo is apparently
mainly cotranslational (recent publications [6^17]), thus a vec-
torial process, and as a consequence of its cotranslational and
vectorial nature one might expect that ribosome itself [17^20]
as well as the translation process could a¡ect the mechanism
and the pathway.
In addition to a link between the level of gene expression
and codon frequency (see [21]), intriguing correlations be-
tween usage/frequencies of synonymous codons and protein
structure have been reported [22^31]. A tendency of rare co-
dons to encode turns, loops and domain linkers was also
observed [22^27]. Since it is known that the ribosome tra⁄c
on a messenger is mainly modulated by both the general de-
generacy of the genetic code (namely speci¢c synonymous
codon usage characteristics for a given organism) and the
availability of cognate tRNAs, surrounding ribosome during
translation, it might be concluded that such regions would be
slowly translated [23^24]. It should be mentioned that within
Escherichia coli and other organisms, a strong codon bias
exists, and the level of cognate tRNAs was shown to be di-
rectly proportional to the frequency of codon usage [32].
Thus, in most of the cases the term rare codon would at the
same time mean slowly translated codon. Since folding is a
modular process [33], one might suggest that optimization of
the in vivo protein folding includes the adaptation of codon
selection along mRNA to a particular translation kinetics [22^
31]. This could be necessary to ensure step-by-step synthesis
and folding of the de¢ned portions of the polypeptide chain
growing on the ribosome from its N-terminal end. Conse-
quently, the regions of slowed down translation might serve
as interpunctuations during protein synthesis separating dif-
ferent folding events [22^31]. Thus, one might suggest that
alteration of translation kinetics could in£uence the in vivo
protein folding pathway. Evidences, showing that optimiza-
tion of heterologous gene expression by a choice of only fre-
quent codons often yields biologically inactive products form-
ing insoluble aggregates, which have to be renatured
arti¢cially in order to regain similarity in structure and bio-
logical activity with native analogues [34^36] could support
the idea. Since it is known that synonymous codons are trans-
lated at di¡erent rates [37,38], it is possible to change the local
rates of translation by suitable selection of synonymous co-
dons. Here, we address a question of a possible link between
protein folding and protein translation by the use of chloram-
phenicol acetyltransferase gene with 16 synonymous rare co-
dons replaced by frequent ones. We have used speci¢c activity
of a protein (synthesized in vitro in E. coli S30 extract cell-free
system) as a measure of its folding state. Our results show that
replacement of a set of rare codons by synonymous frequent
ones at a selected place of the chloramphenicol acetyltransfer-
ase gene led to the acceleration of the ribosome tra⁄c through
the mutated region and at the same time a¡ected the speci¢c
activity of the enzyme (in comparison with a wild-type (wt)
protein), suggesting in vivo protein folding could be in£u-
enced by the rates of translation.
2. Materials and methods
2.1. Plasmid construction and mutagenesis
The pUC18:IM3/CI-1 plasmid bearing the chloramphenicol acetyl-
transferase (CATIII) gene was a gift of Prof. W.V. Shaw (University
of Leicester). The BamHI^HindIII (1034-bp) fragment of the pU-
C18:IM3/CI-1 plasmid was inserted into pBluescript II KS3 vector,
to obtain the gene under control of the T7 promoter. Oligonucleotide
directed mutagenesis was accomplished using single stranded DNA
and following general procedures described in [39]. The following
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2.2. In vitro transcription
The transcription reaction was carried out: (1) following the ’Prom-
ega’ Transcription in vitro systems Technical Manual or (2) according
to Gurevich et al. [40] in 100 Wl (total volume) of 80 mM HEPES-
KOH bu¡er, pH 7.5, containing 16 mM MgCl2, 2 mM spermidine, 20
mM dithiothreitol (DTT), 3 mM ATP, 3 mM GTP, 3 mM UTP, 3
mM CTP, 2.5 Wl (100 units) of RNasin (Promega), 5 Wg of HindIII
(pBluescript II KS3 wtCATIII an its di¡erent derivatives) linearized
DNA templates and 320 units of T7 RNA polymerase (Promega). The
reaction was carried out at 37‡C for 2.5 h and stopped by phenol/
chloroform extraction. The transcript was puri¢ed by LiCl precipita-
tion and washed with 70% ethanol [41]. The purity and integrity of the
RNA molecules were checked by 5% PAGE under denaturing con-
ditions in the presence of 7 M urea. An aqueous solution (0.8 mg/ml)
of the transcripts was used in translation experiments.
2.3. Cell-free protein synthesis and nascent peptide isolation
Cell-free translation of the CATIII mRNAs was performed using
the E. coli S30 extract in vitro translation system in the presence of
[35S]methionine (15 mCi/ml, Amersham) as described in the ‘Promega’
Technical Manual. The ¢nal concentration of CATIII mRNAs was 64
Wg/ml. In some experiments the translation reactions were synchron-
ized by adding 100 WM aurintricarboxylic acid 30 s^1 min after the
addition of mRNA.
To isolate nascent chains the translation reactions were stopped by
the addition of an equal volume of 20 mM Tris-HCl bu¡er, pH 7.6,
200 mM NH4Cl, 20 mM MgCl2, 2 mM DTT and 0.2 mM EDTA cold
on ice (bu¡er A). Extracts were layered on the top of 150 Wl of 30%
glycerol in half concentrated bu¡er A and centrifuged for 1 h at 4‡C
and 100 000 rpm in TLA-100 rotor (Beckman) in order to pellet ribo-
somes. The polysome pellets were suspended in a small volume (10^12
Wl) of 1 mM Tris-HCl bu¡er, pH 7.6 containing 0.5 mg/ml ribonu-
clease A and incubated for 30^45 min at 37‡C. In order to enhance
the hydrolysis of the peptidyl-tRNA ester bond, NaOH was added to
a ¢nal concentration of 10 mM and the incubation was continued for
an additional 30 min.
2.4. Electrophoresis
Cell-free translation products were analyzed using PAGE according
to [42], in either 16.5% T, 6% C or 16.5% T, 3% C (with or without
6 M urea) gels, with an additional spacer gel. The ‘Rainbow 14C-
methylated colored proteins’ (MW = 2350^46 000 Da, Amersham)
were used as molecular weight markers. Gels were ¢xed, dried in
vacuo and subjected to autoradiography using the Molecular Dynam-
ics phosphorimager.
2.5. CATIII activity measurements
The chloramphenicol acetyltransferase activity was measured using
£uorescent FAST CAT Green (Deoxy) Chloramphenicol acetyltrans-
ferase assay kit (Molecular Probes) following general procedures de-
scribed in ‘Molecular Probes Technical Product Manual’ with minor
modi¢cations. The ¢nal concentration of the substrate in the reaction
mixtures was 63 WM, which is well above the KM of V18 WM for this
substrate. The 2.5-Wl aliquots were periodically removed from the
translation reactions and subjected to CAT activity assay measure-
ments in a total 80-Wl volume of the FAST CAT substrate reagent,
containing 1.125 mM acetyl CoA. The assay reactions were performed
at 37‡C for 10^30 min and stopped by adding 1 ml of ice-cold ethyl
acetate. Extracts were evaporated and redisolved in 25 Wl of ethyl
acetate. The reaction substrate and product were resolved by thin-
layer chromatography (TLC) on silica gel 60 plates (Merck) in chlo-
roform:methanol (85:15 v/v) solvent. The unreacted CAT substrate
and the acetylated product derivative were quantitated under UV
using a digital camera with the help of ‘Elscript‘ scan and evaluation
software v 1.4 (Analyse Technik Hirshman GmbH). The speci¢c ac-
tivities were calculated from quantitation of the synthesized 35S-la-
beled protein at the same period of time of translation when samples
for activity assay measurements were removed.
2.6. Miscellaneous
Molecular cloning and sequencing were performed following gen-
eral procedures described in [41]. Radioactivity was monitored using a
PACKARD 2200CA TRI-CARB liquid scintillation analyzer. Tri-
chloroacetic acid precipitable radioactivity was determined in sample
aliquots spotted onto GF/C (Whatman) glass ¢lters after NaOH hy-
drolysis.
3. Results
3.1. Replacement of synonymous codons accelerate ribosome
tra⁄c through the mutated region
In an attempt to elucidate the e¡ect of synonymous codon
substitutions on both ribosome tra⁄c and protein folding we
have replaced 16 rare synonymous codons (located at the
CATIII gene ORF region 123^145) by synonymous frequent
ones. The silent codon substitutions are shown in Fig. 1A.
A method of SDS-PAGE analysis of nascent chains accu-
mulating during CAT translation has been chosen in order to
monitor CAT translation kinetics. PAGE analysis of the nas-
cent peptides (isolated from the polyribosomal fraction)
showed that translation of chloramphenicol acetyltransferase
in vitro is indeed a non-uniform process characterized by spe-
ci¢c pauses (Fig. 1B). The increase in residence time of the
Fig. 1. A: Sequence of the CATIII open reading frame region 120^
150. Silent codon substitutions are shown in bold. B: Autoradio-
gram of SDS gel electrophoresis of CAT nascent chains. 1: nascent
peptides after 3 min of CATIII (silent codon mutant) translation;
2: nascent peptides after 3 min of CATIII (wt) translation. Arrows
point the position of molecular weight markers. Molecular mass is
given in kDa. C: phosphorimager scan of translation products: slots
1 and 2 in (B), respectively.
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ribosome at positions along the mRNA which are character-
ized by low codon frequencies results in increased amounts of
nascent chains of the sizes corresponding to the location of
the respective rare codons. Thus, the gel electrophoresis nas-
cent peptide band pattern re£ects the non-uniform translation
kinetics of the CATIII protein, allowing also to locate the
pause sites from the lengths of the respective nascent chains
(Fig. 1B). Translation pausing during CAT in vitro synthesis
also has been recently reported by Hardesty and co-authors
[43]. Using translation rates of individual codons computed
from available data [44], it can be predicted that silent replace-
ments of the 16 rare codons would result in a two-fold de-
crease in the time needed for a ribosome to move through the
mRNA region ORF 124^145. It was observed that the
amount of the respective nascent chains accumulating during
translation of the silently mutated (sm) protein decreased sig-
ni¢cantly, by a factor of 2.7 (as can be concluded from phos-
phorimager scan data) and even one particular peptide (amino
acid length 133^136) disappeared almost completely (Fig.
1B,C). This indicates that the ribosome is in fact moving
faster through the mutated region.
It was also found that the total amount of the sm protein
synthesized in E. coli S30 extract (TCA precipitated material
as well as full-length protein) exceeds by 12^16% that for the
wt protein (not shown). It is unlikely that this result originates
from the higher level of initiation in case of sm mRNA in
comparison with the wt. When the translation reactions were
synchronized by the addition of aurintricarboxylic acid (inhib-
itor of initiation of protein synthesis [45]) essentially the same
results were obtained.
3.2. Silently mutated protein shows reduced speci¢c activity
The major question we were addressing in this study was
whether the alterations of translation kinetics could a¡ect
chloramphenicol acetyltransferase folding during translation
in vitro. Since a link between structure and function of pro-
teins is a well established fact, one can use speci¢c activity of a
given protein as measure of its folding state. It was therefore
of interest to compare the speci¢c activities of CATs trans-
lated from the natural and the sm mRNAs. We have used
equal amounts of mRNAs for both wt and sm protein pro-
duced in a separate set of translation experiments, which were
run simultaneously under equal conditions. Periodically sam-
ple aliquots were removed and both the total amount of the
synthesized protein (as well as full-length polypeptide) and the
chloramphenicol acetyltransferase activity were measured.
Surprisingly, we found that CATIII produced from the sm
gene displayed reduced speci¢c activity in comparison with
that for the wt protein. The overall di¡erence in speci¢c ac-
tivity (ratio of activity over protein amount) was found to be
20% (Fig. 2).
4. Discussion
One of the major open questions in molecular biology is to
what extent protein folding models developed using in vitro
approaches re£ect the in vivo situation. Many attempts to
achieve in vitro 100% refolding of the denatured proteins
were only partially successful. This indicates that apparently
additional information supplementing the amino acid se-
quence and additional factors should probably be considered.
It is now known that chaperones and folding catalysts appear
to be mainly involved in kinetic partitioning between proper
folding and aggregation; thus they a¡ect the yield rather than
the folding mechanism [46,47]. It is therefore likely that some
Fig. 2. Speci¢c activities of the chloramphenicol acetyltransferase
variants synthesized in E. coli S30 extract cell-free system. Maxi-
mum value of the speci¢c CAT activity in each independent transla-
tion experiment was set to 100%. Average values of ¢ve experiments
are shown. Speci¢c activity was determined as a ratio of the per-
centage of substrate conversion (to acetylated product) to the total
amount of the 35S-labeled protein synthesized during the de¢ned pe-
riod of times.
Fig. 3. Schematic representation of possible in£uence of translation
pausing on cotranslational protein folding and misfolding.
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additional factors, and in particular kinetics of protein trans-
lation should be taken into account [22^31]. It was therefore
of interest to investigate the direct e¡ect of the changes of the
rates and kinetics of translation on protein folding. It should
be mentioned that conditions of in vitro translation closely
resemble that of the in vivo protein synthesis [48,49]. In addi-
tion the in vitro system possesses several advantages, allowing
e.g. easily to control the amount of the mRNA added and the
protein synthesized.
4.1. CAT translation and folding in E. coli S30 extract system
We have replaced 16 rare codons by frequent ones at a
selected place of CATIII gene and compared the translation
and folding (as measured by the speci¢c CAT activity) of the
wt and sm protein. Our data show that the silent codon ex-
changes a¡ect ribosome tra⁄c at a mutated region of CATIII
mRNA and abolish particular translational pause. A lot of
experimental data provide evidence that rates of chain elon-
gation during translation of proteins are not uniform (see
[23]). Non-uniform character of distribution of codons with
di¡erent usage frequencies along mRNA is assumed to be a
main factor which modulates the translation kinetics. Inten-
sive studies have been carried out previously on the determi-
nation of the translation rates of certain individual codons
[37,38] as well as on the determination of the e¡ect of synon-
ymous codon usage on the overall level of gene expression
[50^53]. However, there are at present only few data directly
showing that replacement of certain synonymous codons
could lead to the alteration of ribosome tra⁄c on mRNA at
a selected place [54]. Our data clearly corroborate this obser-
vation.
As a next step we have compared the speci¢c activities of
the sm and wt protein. We found sm protein to possess about
20% lower speci¢c activity. Since speci¢c activity of a given
protein could be considered as a measure of its proper folding
one might conclude that CATIII folding was a¡ected. It can
be suggested that accelerated rates of translation of a selected
region allowed the particular part of the polypeptide chain to
appear earlier in time during translation in comparison with
the wt protein. This could lead to an a¡ected interaction of
this polypeptide region with the preceding one, which (one
may speculate) was not yet properly folded (due to a lack
of time). Such misfolded nascent chains can further undergo
enhanced interaction with chaperones (due to an altered chap-
erone a⁄nity) and this could shift the equilibrium back to the
productive folding pathway. Alternatively, such misfolded
nascent chains could be trapped and ¢nally degrade (Fig. 3).
The phenomenon of cotranslational ubiquitination (and deg-
radation) of proteins [55^57] clearly supports the idea that
misfolding of proteins could start during protein translation.
Cotranslational folding is assumed to be a modular process
proceeding by parts and thus one can conclude that the for-
mation of the normal intermediate(s) on a cotranslational
CAT folding pathway was probably a¡ected. Codon substitu-
tions were introduced in a region (ORF 123^145) represented
in a CAT three-dimensional structure by a long loop and a
beta-sheet [58,59]. This region bears the Ser residue (at posi-
tion 142), which is known to be of catalytic importance and
absolutely conserved among all CATs [60,61]. Also this region
is in part involved in subunit interactions.
The observed drop in a speci¢c activity in case of sm pro-
tein could be, however, explained by a number of reasons.
Since CATIII is active only in a form of a trimer [60,61]
one can suggest that polypeptides produced from the sm
mRNA:
be only in part able to form trimers (80% of the wt), as
those unable to form trimers bear some folding ‘defects’
which does not allow trimer formation and e.g. represent
more e⁄cient target for chaperones, in particular DnaJ,
DnaK and GroEL;
could form trimers, among which only 80% are active,
again due to some folding ‘defects’ which leave 20% of
the trimers inactive;
could form trimers which possess only 80% of speci¢c
activity, compared to the wt protein due to the incorrect
architecture of the active site.
Further experiments will be required to explore these sug-
gestions.
The fact that the di¡erence in speci¢c activity remains un-
changed during the time of translation and even (20 min) after
the moment, when CATIII translation is stopped by puromy-
cin (results not shown) indicates that improper folding CAT-
III ‘variants’ are trapped and stable.
Taking together all the data mentioned above we argue that
folding of CAT can be a¡ected by the rates of translation and
location of speci¢c pauses.
It was reported previously that replacement of ten consec-
utive non-preferred codons in the indoleglycerol-phosphate
synthase region of the TRP3 gene with synonymous preferred
codons causes a 1.5-fold reduction in relative indoleglycerol-
phosphate synthase activity observed during expression of the
protein in yeast cells [62]. Likewise the authors concluded that
translational pausing promotes the correct intracellular fold-
ing of the TRP3 protein. The importance of pausing was also
demonstrated in case of signal recognition particle receptor
alpha-subunit cotranslational assembly and membrane bind-
ing (in a rabbit reticulocyte lysate cell-free translation system)
[54].
One might suggest that both in eukaryotic and prokaryotic
cells speci¢c features of non-uniform translation could be nec-
essary to ensure proper in vivo protein folding.
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